ストックスクリーナーアプリを入手
103.41
0.57%
0.59
アフターアワーズ：
103.00
-0.41
-0.40%
Lantheus Holdings Inc (LNTH) 最新ニュース
Lantheus Holdings Inc focuses on diagnostic imaging growth - AD HOC NEWS
Lantheus Holdings Inc (LNTH) Stock Down 6.4% but Still Overvalued -- GF Score: 82/100 - GuruFocus
Lantheus Holdings stock hits 52-week high at 90.5 USD - Investing.com
Lantheus Q1 2026 slides: regulatory wins fuel growth transition - Investing.com
Did FDA’s Facility-Related LNTH-2501 Delay and Russell Additions Just Reframe Lantheus Holdings’ (LNTH) Risk Profile? - Sahm
LNTHLantheus Holdings Inc Latest SEC Filings - Finviz
Lantheus Holdings Inc focuses on diagnostic imaging and radiopharmaceutical growth - AD HOC NEWS
Lantheus receives complete response letter for LNTH-2501 - MSN
Lantheus Holdings stock hits 52-week high at 111.52 USD By Investing.com - Investing.com South Africa
Lantheus Holdings stock hits 52-week high at 111.52 USD - Investing.com
LNTH Reiterated by Citizens -- Price Target Maintained at $115 - GuruFocus
What's Going On With Lantheus Stock Monday?Lantheus Holdings (NASDAQ:LNTH) - Benzinga
Lantheus stock holds at Market Outperform despite FDA setback By Investing.com - Investing.com South Africa
Lantheus stock holds at Market Outperform despite FDA setback - Investing.com
Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio - DirectorsTalk Interviews
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday - Benzinga
Lantheus Holdings, Inc.(NasdaqGM: LNTH) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Lantheus Holdings, Inc.(NasdaqGM: LNTH) added to Russell 2000 Defensive Index - marketscreener.com
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. C - The National Law Review
LNTH STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Liquidity Mapping Around (LNTH) Price Events - Stock Traders Daily
William Blair Maintains Lantheus(LNTH.US) With Buy Rating - Moomoo
FDA issues complete response letter for Lantheus’ NET imaging drug By Investing.com - Investing.com Nigeria
Lantheus (LNTH) Faces FDA Response on LNTH-2501 Application - GuruFocus
Lantheus (LNTH) Faces Setback with FDA Response on LNTH-2501 - GuruFocus
FDA issues complete response letter for Lantheus’ NET imaging drug - Investing.com
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues - Reuters
Lantheus stock falls after FDA rejects drug application By Investing.com - Investing.com South Africa
Lantheus stock falls after FDA rejects drug application - Investing.com
Lantheus Gets FDA Complete Response Letter for LNTH-2501 - Moomoo
Lantheus Application for Tumor Imaging Drug Rejected Due to Manufacturing Concerns - marketscreener.com
Price to sales forward of Lantheus Holdings, Inc. – NASDAQ:LNTH - TradingView
US FDA declines to approve Lantheus’ tumor imaging kit - Yahoo Finance
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide) - The Manila Times
Price to book forward of Lantheus Holdings, Inc. – NASDAQ:LNTH - TradingView
Price to book forward of Lantheus Holdings Inc – XETR:0L8 - TradingView
Price to earnings forward of Lantheus Holdings Inc – XETR:0L8 - TradingView
Price to sales forward of Lantheus Holdings Inc – XETR:0L8 - TradingView
Why Is LNTH Stock Up After Hours? - Stocktwits
A Look at Lantheus Holdings Inc (LNTH) After 3.9% Gain -- GF Val - GuruFocus
Lantheus Holdings Inc Actuals & Estimates (NASDAQ:LNTH) - TradingView
Lantheus Holdings Inc Actuals & Estimates (XETR:0L8) - TradingView
LNTH Forecast — Price Target — Prediction for 2027 - TradingView
0L8 Forecast — Price Target — Prediction for 2027 - TradingView
Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest - Yahoo Finance
Lantheus Holdings stock hits 52-week high at 107.99 USD By Investing.com - Investing.com Australia
Lantheus Holdings stock hits 52-week high at 107.99 USD - Investing.com
0.15%
1.95%
大文字化:
|
ボリューム (24 時間):